Literature DB >> 20448111

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.

Masako Iwanaga1, Toshiki Watanabe, Atae Utsunomiya, Akihiko Okayama, Kaoru Uchimaru, Ki-Ryang Koh, Masao Ogata, Hiroshi Kikuchi, Yasuko Sagara, Kimiharu Uozumi, Manabu Mochizuki, Kunihiro Tsukasaki, Yoshio Saburi, Masaomi Yamamura, Junji Tanaka, Yukiyoshi Moriuchi, Shigeo Hino, Shimeru Kamihira, Kazunari Yamaguchi.   

Abstract

Definitive risk factors for the development of adult T-cell leukemia (ATL) among asymptomatic human T-cell leukemia virus type I (HTLV-1) carriers remain unclear. Recently, HTLV-1 proviral loads have been evaluated as important predictors of ATL, but a few small prospective studies have been conducted. We prospectively evaluated 1218 asymptomatic HTLV-1 carriers (426 males and 792 females) who were enrolled during 2002 to 2008. The proviral load at enrollment was significantly higher in males than females (median, 2.10 vs 1.39 copies/100 peripheral blood mononuclear cells [PBMCs]; P < .001), in those 40 to 49 and 50 to 59 years of age than that of those 40 years of age and younger (P = .02 and .007, respectively), and in those with a family history of ATL than those without the history (median, 2.32 vs 1.33 copies/100 PBMCs; P = .005). During follow-up, 14 participants progressed to overt ATL. Their baseline proviral load was high (range, 4.17-28.58 copies/100 PBMCs). None developed ATL among those with a baseline proviral load lower than approximately 4 copies. Multivariate Cox analyses indicated that not only a higher proviral load, advanced age, family history of ATL, and first opportunity for HTLV-1 testing during treatment for other diseases were independent risk factors for progression of ATL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448111     DOI: 10.1182/blood-2009-12-257410

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  123 in total

1.  Multiplex Droplet Digital PCR Assay for Quantification of Human T-Cell Leukemia Virus Type 1 Subtype c DNA Proviral Load and T Cells from Blood and Respiratory Exudates Sampled in a Remote Setting.

Authors:  David Yurick; Georges Khoury; Bridie Clemens; Liyen Loh; Hai Pham; Katherine Kedzierska; Lloyd Einsiedel; Damian Purcell
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma.

Authors:  Andrew Hodson; Daniel J Laydon; Barbara J Bain; Paul A Fields; Graham P Taylor
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

3.  SIRT1 Suppresses Human T-Cell Leukemia Virus Type 1 Transcription.

Authors:  Hei-Man Vincent Tang; Wei-Wei Gao; Chi-Ping Chan; Yun Cheng; Jian-Jun Deng; Kit-San Yuen; Hidekatsu Iha; Dong-Yan Jin
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

4.  Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study.

Authors:  Madoka Kuramitsu; Kazu Okuma; Tadanori Yamochi; Tomoo Sato; Daisuke Sasaki; Hiroo Hasegawa; Kazumi Umeki; Ryuji Kubota; Rieko Sobata; Chieko Matsumoto; Noriaki Kaneko; Isao Naruse; Makoto Yamagishi; Makoto Nakashima; Haruka Momose; Kumiko Araki; Takuo Mizukami; Saeko Mizusawa; Yoshiaki Okada; Masaki Ochiai; Atae Utsunomiya; Ki-Ryang Koh; Masao Ogata; Kisato Nosaka; Kaoru Uchimaru; Masako Iwanaga; Yasuko Sagara; Yoshihisa Yamano; Masahiro Satake; Akihiko Okayama; Manabu Mochizuki; Shuji Izumo; Shigeru Saito; Kazuo Itabashi; Shimeru Kamihira; Kazunari Yamaguchi; Toshiki Watanabe; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

5.  Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia.

Authors:  Sanaz Firouzi; Amir Farmanbar; Kenta Nakai; Masako Iwanaga; Kaoru Uchimaru; Atae Utsunomiya; Yutaka Suzuki; Toshiki Watanabe
Journal:  Blood Adv       Date:  2017-06-27

6.  Transition of adult T-cell leukemia/lymphoma clones during clinical progression.

Authors:  Sakura Aoki; Sanaz Firouzi; Yosvany López; Tadanori Yamochi; Kazumi Nakano; Kaoru Uchimaru; Atae Utusnomiya; Masako Iwanaga; Toshiki Watanabe
Journal:  Int J Hematol       Date:  2016-07-06       Impact factor: 2.490

7.  A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.

Authors:  Yuko Ishihara; Yukie Tanaka; Seiichiro Kobayashi; Koji Kawamura; Hideki Nakasone; Ayumi Gomyo; Jin Hayakawa; Masaharu Tamaki; Yu Akahoshi; Naonori Harada; Machiko Kusuda; Kazuaki Kameda; Tomotaka Ugai; Hidenori Wada; Kana Sakamoto; Miki Sato; Kiriko Terasako-Saito; Misato Kikuchi; Shun-Ichi Kimura; Aki Tanihara; Shinichi Kako; Kaoru Uchimaru; Yoshinobu Kanda
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

8.  Carnosol, rosemary ingredient, induces apoptosis in adult T-cell leukemia/lymphoma cells via glutathione depletion: proteomic approach using fluorescent two-dimensional differential gel electrophoresis.

Authors:  Yo-ichi Ishida; Masao Yamasaki; Chizuko Yukizaki; Kazuo Nishiyama; Hirohito Tsubouchi; Akihiko Okayama; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2013-12-10       Impact factor: 4.174

Review 9.  "Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).

Authors:  Paul A Fields; Graham P Taylor
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

Review 10.  Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.

Authors:  Noriaki Yoshida; Dai Chihara
Journal:  Curr Treat Options Oncol       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.